>PROKKA_00001 hypothetical protein
MDANITDAIASIVWYPSSKDFEKAPLNPVDIVGPRGETNPLIIIIANITNKAGVKTLPIL
STIPDGLNTNAKQTRK*
>PROKKA_00002 hypothetical protein
VVAAVLGIASIGPIANINAVVDIIANIFPTLPDISENVPFILAQAIIPVNGKPTPVIKKP
IIAAGA*
>PROKKA_00003 Dihydroorotase
LVLLIKNGKVLTMTDKKHVNDCILINNGKIEKIAKKIETDNESIEVIDAKGGWVMPGIID
AHCHIGIMEEGIKFEGMDLNEYSSAITPHLRAIDGINPRDLAFQSAIEAGITTVMTGMGS
SNPIGGQFAIIKTYGKSVDEMVVKAPAALKIAFGENPKSIFGKKGSMPITRMGTAALIRE
TLYKAKNYMNRKEEALKEGKIFDIDIKMESIIPVLKREIPLKAHAHRSDDILTAIRIAKE
FDLKLTIDHGTEAHLVADYIKESGFPVIAGPNMNFRGKVETKNRSYNTTKILQEKEILYA
MITDHPVVPIEFLPMSAALAVKNGLKEEDALKAITINPAKILGIEHRVGTLDVGKEADIC
IYNDNPLNMNSKNMYTIISGNIVYDFNKNL*
>PROKKA_00004 hypothetical protein
MHFCRKCGNKLQENSKRCNTCGSELEKIHKEEISSITDKEKLLDNEIFNDEHILKYKEEP
LEIIRKFNLIKKIKENKVFLIAILVLIIIVTPLIKNPIKNFVIRKNPANWLVYAADKCKK
SDTLDTVSDFKIKSTVESQEFMNYKDIENIIEQCTLRVNNKINKTTNERYSKISLIYKEE
NILNGEIYSNKEYMAISMPQLYKDIMYIKWEDVNKLINNNKENKNISETIDPKNYENVLN
IKKSKYYDNVNGDYREFFNKIMDDYVQRGDKVDIVTKQEDKEKTIKCDEIVVHLDNERII
KILNAFFQKVSKDENLKLLVRDKVFEFLSTVQKNQDLNKFNLSKEEADNIKRDFDSEYDS
FMKELSHVEKIDKKASNGKINSLTKVKIDSRNYIRGLQSEISIDKKKTSFNFISNTVINS
IDSKLDIKKISKEGAKDISKFTAKDREDIAIGMENNIQKVMFSKLNIK*
>PROKKA_00005 hypothetical protein
MESTQIMSFLREELIKQLIKETKLISAKGVQETLKDIFTNIFKGMLEAKLDNHLGYSDLI
LPRDIEGSFDLQVMKKNRNHILIVFDKFI*
>PROKKA_00006 Botulinum neurotoxin type B precursor
MPVTINNFNYNDPIDNNNIIMMEPPFARGTGRYYKAFKITDRIWIIPERYTFGYKPEDFN
KSSGIFNRDVWEYYDPDYLNTNDKKNIFLQTMIKLFNRIKSKPLGEKLLEMIINGIPYLG
DRRVPLEEFNTNIASVTVNKLISNPGEVERKKGIFANLIIFGPGPVLNENETIAIGIQNH
FASREGFGGIMQMKFCPEYVSVFNNVQENKGASIFNRRGYFSDPALILMHELIHVLHGLY
GIIVNDLPIVPNEKKFFMQSTDAIQAEELYTFGGQDPSIISPSTDKSIYDKVLQNFRGIV
DRLNKVLVCISDPNININIYKNKFKDKYKFVEDSEGKYSIDVESFDKLYKSLMFGFTETN
IAENYKIKTRASYFSDSLPPVKIKNLLDNEIYTIEEGFNISDKDMEKEYRGQNKAINKQA
YEEISKEHLAVYKIQMCKSVKAPGICIDVDNEDLFFIADKNSFLDDLSKNERIEYNTQSN
YIENDFPINELILDTDLISKIELPSENTESLTDFNVDVPVYEKQPAIKKIFTDENTIFQY
LYSQTFPLDIRDISLTSSFDDALLFSNKVYSFFSMDYIKTANKVVEAGLFAGWVKQIVND
FVIEANKSNTMDKIADISLIVPYIGLALNVGNETAKGNFENAFEIAGASILLEFIPELLI
PVVGAFLLESYIDNKNKIIKTIDNALTKRNEKWSDMYGLIVAQWLSTVNTQFYTIKEGMY
KALNYQAQALEEIIKYRYNIYSEKEKSNINIDFNDINSKLNEGINQAIDNINNFINGCSV
SYLMKKMIPLAVEKLLDFDNTLKKNLLNYIDENKLYLIGSAEYEKSKVNKYLKTIMPFDL
SIYTNDTILIEMFNKYNSEILNNIILNLRYKDNNLIDLSGYGAKVEVYDGVELNDKNQFK
LTSSANSKIRVTQNQNIIFNSVFLDFSVSFWIRIPKYKNDGIQNYIHNEYTIINCMKNNS
GWKISIRGNRIIWTLIDINGKTKSVFFEYNIREDISEYINRWFFVTITNNLNNAKIYING
KLESNTDIKDIREVIANGEIIFKLDGDIDRTQFIWMKYFSIFNTELSQSNIEERYKIQSY
SEYLKDFWGNPLMYNKEYYMFNAGNKNSYIKLKKDSPVGEILTRSKYNQNSKYINYRDLY
IGEKFIIRRKSNSQSINDDIVRKEDYIYLDFFNLNQEWRVYIYKYFKKEEEKLFLAPISD
SDEFYNTIQIKEYDEQPTYSCQLLFKKDEESTDEIGLIGIHRFYESGIVFKEYKDYFCIS
KWYLKEVKRKPYNSKLGCNWQFIPKDEGWTE*
>PROKKA_00007 Botulinum neurotoxin type A precursor
MCVEINLGEWLDMNINDNLSINSPVDNKNVVVVRARKTDTFFKAFKVAPNIWVAPERYYG
ESLSIDEEYKVDGGIYDSNFLSQDSEKDKFLQAIITLLKRINSTNAGEKLLSLISTAIPF
PYGYIGGGYYAPNMITFGSAPKSNKKLNSLISSTIPFPYAGYRETNYLSSEDNKSFYASN
IVIFGPGANIVENNTVFYKKEDAENGMGTMTEIWFQPFLTYKYDQFYIDPAIELMKCLIK
SLYFLYGIKPSDDLVVPYRLRNELENIEYSQLDIVDLLVSGGIDPKFINTDPYWFIDNYF
SNAKKMFEDHRNIYETEIEGNNAIGNDIKLRLKQKFRININDIWELNLNYFSKEFNIMMP
DRFNNALKHFYRKQYYKIDYPENYSINGFVNGQINAQLSLSDRNQDIINKPEEIINLLNE
NNVLLMRSNIYGDGLKSTVDDFYSNYKIPYNRAYEYHFNNSNDSSLDNVNVGVIDNIPEI
IDVNPYRKNCDPFTPVYNITETKEINTTIPFSVNYLQAQNANNEKFSLSSDFVEVVSSKD
KSLAYSFLSNVMFYLDSIKDNSPIDTDKEYYLWLREIFRNYSFDITATQEINTNCGINKV
VTWFGKALNILNTSDSFVEEFQNLGPISLINKKENLSMPIIEIYEIPNDMLGLPLNDLNE
KLFNIYLKNILYFKKVYFNFLDQWWTEYYSQYFDLICMAKQSILAQEKLIKQIIQNKLQD
LSKADISMDKLNLMNLATEKTFIDLSNESQIAINNINDFLNKSAICVFDTNIYPKFISFM
EQCINSVNSNVTAFIQKCTNITEDEKLQLIKLNTFMNIDFEFFDIQSIKDLITSETDLIK
EEKESDYNLFLFTLQEDNNKVIEDISGKNTLVKYSDSISLVYGVNGDALYLKEPDESVSF
SNKAFENGLTNSFSICFWLRNLGEDIITSKLIENKADNCGWEIYFQNNGLVFSIVDCNGN
EENIYLSDVISKNWYYISISIDRLRNQLLIFINDKLIANQSIEQILNIYSSNTISLVNGN
NPIYVEGLSILNRSITSEEVVNNYFSYLNNSYIRDISGERLEYNKTYELYNYVFSENSLY
EVTENNNIYLSIKDTNNLNIQGAKFKLINIDTNKQYVQKWDEGVVCLLGDEEKYVDISSE
NNRIQLVSSKDTAKRIIFNNDIFRPNCLTFAYNNKYLSLSFRDRNYNWMICNNNDNIPKA
AHLWALKGI*
>PROKKA_00008 transcriptional regulator BotR, P-21
MNKLFLQIKMLKNDNREFQEIFKHFEKTINIFTRKYNIYDNYNDILYHLWYTLKKVDLSN
FNTQNDLERYISRTLKRYCLDICNKRKIDKKIIYNSEIVDKKLSLIANSYSSYLEFEFND
LISILPDDQKKIIYMKFVEDIKEIDIAKKLNISRQSVYKNKIMALERLEPILKKLINM*
>PROKKA_00009 hypothetical protein
MEHYSVIQNSLNDKIVTISCKADTNLFFYQVAGNVSLFQQTRNYLERWRLIYDSNKAAYK
IKSMDIHNTNLVLTWNAPTHNISTQQDSNADNQYWLLLKDIGNNSFIIASYKNPNLVLYA
DTVARNLKLSTLNNSNYIKFIIEDYIISDLNNFTCKISPILDLNKVVQQVDVTNLNVNLY
TWDYGRNQKWTIRYNEEKAAYQFFNTILSNGVLTWIFSNGNTVRVSSSNDQNNDAQYWLI
NPVSDTDETYTITNLRDTTKALDLYGGQTANGTAIQVFNYHGDDNQKWNIRNP*
>PROKKA_00010 HA 17 kDa subunit
MSVERTFLPNGNYNIKSIFSGSLYLNPVSKSLTFSNESSANNQKWNVEYMAENRCFKISN
VAEPNKYLSYDNFGFISLDSLSNRCYWFPIKIAVNTYIMLSLNKVNELDYAWDIYDTNEN
ILSQPLLLLPNFDIYNSNQMFKLEKI*
>PROKKA_00011 Hemagglutinin components HA-22/23/53 precursor
MNSSIKKIYNDIQEKVINYSDTIDLADGNYVVRRGDGWILSRQNQILGGSVISNGSTGIV
GDLRVNDNAIPYYYPTPSFNEEYIKNNIQTVFTNFTEANQIPIGFEFSKTAPSNKNLYMY
LQYTYIRYEIIKVLQHEIIERAVLYVPSLGYVKSIEFNPGEKINKDFYFLTNDKCILNEQ
FLYKKILETTKNIPTNNIFNSKVSSTQRVLPYSNGLYVINKGDGYIRTNDKDLIGTLLIE
AGSSGSIIQPRLRNTTRPLFTTSNDTKFSQQYTEERLKDAFNVQLFNTSTSLFKFVEEAP
SDKNICIKAYNTYEKYELIDYQNGSIVNKAEYYLPSLGYCEVTNAPSPESEVVKMQVAED
GFIQNGPEEEIVVGVINPSENIQEINTAISDNYTYNIPGIVNNNPFYILFTVNTTGIYKI
NAQNNLPSLKIYEAIGSGNRNFQSGNLCDDDIKAINYITGFDSPNAKSYLVVLLNKDKNY
YIRVPQTSSNIENQIKFKREEGDLRNLMNSSVNIIDNLNSTGAHYYTRQSPDVHDYISYE
FTIPGNFNNKDTSNITLYTSYNQGIGTLFRVTETIDGYNLINIQQNLNLLNSTKSIRLLN
GAIYILKVEVTELNNYNIRLHIDITN*
>PROKKA_00012 hypothetical protein
MGTRLKELSLIYKNNTLNEDDKKNIEYEAKSLLDNMYFTIKNTKFNGKNLFTGEKLNIQG
STYNTDIKLMDFKVPKEDSIFIGNNKSSNESHTIKISDTEIDVILKKYNLEKANKIIFYE
SEMVDKHNIKTVFTSKYGYKNNANIDIVNVSNNVNKMFSINGTINDNSEVKGYLQEEDNK
LIGNININDKEYNIQLETTMEYALKTNLNSIKTTIINKNNHTFRGNTSIVDIQDNSGMTY
TSKEITIYEFKEIIANNKSNNKNKQIVFELSNNKKITFDINNKDINLYIFDEEYNSFDIS
DILNSSNIIEEKVLSELNNYQNYIGIKTNELEYKLNFEQNNQIL*
>PROKKA_00013 hypothetical protein
MKLSTNKKVNIAADSPSEIERINRINTSVRSRNIAVRIFKKEYLYYK*
>PROKKA_00014 hypothetical protein
MKIKHTKVNEYYNYLKESFANVNLSEEHRMDIYKKIEIIEALVSLYEQKYEFDDEIIEDL
KLKYRPVFPEELKNIQKNLEKTIIK*
>PROKKA_00015 hypothetical protein
MGKRGEVLKVNKITIVGEFMHFKISYIIATKLVYNRKC*
>PROKKA_00016 hypothetical protein
MSMDIPEYLIETIFENIDQRLKQNFYNFYENLFNMNNKEENLKLLIKDIIQREFIVAELT
KISDMDLHKTKHTFIAPNKVNKLKRYNLQQIKQTKKDGIIHYLKRKKQIH*
>PROKKA_00017 hypothetical protein
LKYWLDNSIFVTNFFYLKSETNKQINITFNLDFIYNICTIISDKWNNNLNFIYMEYPRLL
LDHSLVADGSEKVKVQKQTIIQQNHSNKDVKYKYNDYVPKNRIARILVPESNIDTKQSRL
IYNKDLNILSNILKYKKADFLTNKTIIFNLIDIINNIYCSKIIRSYEDLRNRIAKMTLLK
FNFFRTDNTSGIPDAVYGIFSSYEYLDKSQNKVKVYVDSILYDKILKNQVSTIYNDKINQ
FEISDLFSNKNTSDILPVI*
>PROKKA_00018 hypothetical protein
MHDKNIHNYCNNKYKKIIKKYKIYNNINIDKTYIQFSLTQIKQMLVYYYANSKGFVSLIS
KKRIARMIGCCEKNIDINNKLFLDLGLILISSTINNKFSLIIKNYSEHYSKNNTRYLNLA
TNVLRT*
>PROKKA_00019 hypothetical protein
MKTFLPDYINCKSAIEKVINKLNRNTITMLFNNSEKLIFVISKNLHGKLLKKEMYYKYKN
NFLNYITENNIKLNNLIYSINNIIKLAFEYGYDIIQLILGEIKAIAPTIFNVGRYI*
